Showing results (611-620 of 1,675) with videos related to

Sort By:
Pageof 168
Andrology|July 10, 2020
The impact of metabolically healthy obesity in primary infertile men: Results from a cross-sectional studyWalter Cazzaniga, Luigi Candela, Luca Boeri, et al.
Iscience|November 17, 2022
Patient-specific forecasting of postradiotherapy prostate-specific antigen kinetics enables early prediction of biochemical relapseGuillermo Lorenzo, Nadia di Muzio, Chiara Lucrezia Deantoni, et al.
European Urology|April 21, 2020
Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral CentresRiccardo Campi, Daniele Amparore, Umberto Capitanio, et al.
Theranostics|March 17, 2025
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer - a systematic review and meta-analysisGaia Ninatti, Pietro Scilipoti, Cristiano Pini, et al.
European Urology Oncology|November 9, 2023
Could a Risk-adapted Approach Support Shared Decision-making Regarding Eligibility for Adjuvant Pembrolizumab for Patients with Clear Cell Renal Cell Carcinoma at High Risk of Recurrence? A Multicentre Cohort StudyRiccardo Campi, Alessio Pecoraro, Eduard Roussel, et al.
European Urology|April 15, 2004
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional studyAndrea Salonia, Giuseppe Zanni, Rossella E Nappi, et al.
European Urology|February 13, 2007
Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissectionAlberto Briganti, Pierre I Karakiewicz, Felix K-H Chun, et al.
Clinical Genitourinary Cancer|May 26, 2015
Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume InstitutionMarco Moschini, Paolo Dell' Oglio, Paolo Capogrosso, et al.
Critical Reviews in Oncology/Hematology|August 28, 2022
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysisGiuseppe Fallara, Federico Belladelli, Daniele Robesti, et al.
Cancer|October 18, 2007
Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinomaGeorg C Hutterer, Jean-Jacques Patard, Marc Colombel, et al.
Pageof 168